Myocarditis Following COVID-19 Vaccination: A Comprehensive Review
0
The discovery of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in December 2019 led to an urgent global focus on developing vaccines to combat the spread and severity of COVID-19. The Pfizer-BioNTech COVID-19 vaccine was granted emergency use authorization by the US Food and Drug Administration (FDA) on December 11, 2020, followed by Moderna and Janssen/Johnson & Johnson vaccines. As of April 2022, over 11.5 billion COVID-19 vaccine doses have been administered...
